Pacritinib Targets IRAK1 and Shows Synergy with HDAC and BET Inhibitors in Acute Myeloid Leukemia

被引：4

作者：

Puri, Alka ^{[1
]}

Mahmood, Shawn ^{[1
]}

Maertens, Bernadette ^{[1
]}

Davare, Monika ^{[2
]}

Kurtz, Stephen E. ^{[1
]}

Tognon, Cristina E. ^{[1
,3
]}

Eden, Christopher O. ^{[1
]}

Elferich, Johannes ^{[4
]}

Shinde, Ujwal ^{[4
]}

Druker, Brian J. ^{[1
,3
]}

Singer, Jack W. ^{[5
]}

Agarwal, Anupriya ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR USA

[2] Oregon Hlth & Sci Univ, Pape Pediat Res Inst, Dept Pediat, Portland, OR USA

[3] Howard Hughes Med Inst, Portland, OR USA

[4] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR USA

[5] CTI BioPharma Corp, Seattle, WA USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.3514.3514

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3514

引用

页数：5

共 50 条

[21] Disruption of CTCF Boundary at HOXA Locus Promote BET Inhibitors' Therapeutic Sensitivity in Acute Myeloid Leukemia
Zha, Jie
Lai, Qian
Deng, Manman
Shi, Pengcheng
Zhao, Haijun
Chen, Qinwei
Wu, Hua
Xu, Bing
STEM CELL REVIEWS AND REPORTS, 2020, 16 (06) : 1280 - 1291
[22] Disruption of CTCF Boundary at HOXA Locus Promote BET Inhibitors’ Therapeutic Sensitivity in Acute Myeloid Leukemia
Jie Zha
Qian Lai
Manman Deng
Pengcheng Shi
Haijun Zhao
Qinwei Chen
Hua Wu
Bing Xu
Stem Cell Reviews and Reports, 2020, 16 : 1280 - 1291
[23] Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
Angela Nebbioso
Nicole Clarke
Emilie Voltz
Emmanuelle Germain
Concetta Ambrosino
Paola Bontempo
Rosana Alvarez
Ettore M Schiavone
Felicetto Ferrara
Francesco Bresciani
Alessandro Weisz
Angel R de Lera
Hinrich Gronemeyer
Lucia Altucci
Nature Medicine, 2005, 11 : 77 - 84
[24] Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
Nebbioso, A
Clarke, N
Voltz, E
Germain, E
Ambrosino, C
Bontempo, P
Alvarez, R
Schiavone, EM
Ferrara, F
Bresciani, F
Weisz, A
de Lera, AR
Gronemeyer, H
Altucci, L
NATURE MEDICINE, 2005, 11 (01) : 77 - 84
[25] A Pan-BET Degrader Shows Broad Pre-Clinical Activity in a Large Acute Myeloid Leukemia Cohort
Kandarpa, Malathi
Peterson, Luke
Potu, Harish
Liu, Yihong
Polk, Avery
Wang, Shaomeng
Talpaz, Moshe
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S212 - S212
[26] Targeting IKZF1 via HDAC1: Combating Acute Myeloid Leukemia
Balaji, Sathyanarayan
Anbarasu, Suvitha
Ramaiah, Sudha
Anbarasu, Anand
INTEGRATIVE BIOLOGY, 2024, 16
[27] BET INHIBITORS SYNERGIZE WITH ANTI-PD1 BY RESCUING TCF1+PROGENITOR EXHAUSTED T CELLS IN ACUTE MYELOID LEUKEMIA
Romine, Kyle
Cho, Hyun-Jun
Kosaka, Yoko
Byrd, Kaelan
Coy, Jesse
Flynn, Patrick
Newman, Matthew
Loo, Christopher
Lind, Evan
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A764 - A765
[28] BET inhibitors synergize with anti-PD1 by rescuing TCF1+progenitor exhausted T cells in Acute Myeloid Leukemia
Romine, Kyle Alexander
Cho, Hyun-Jun
Kosaka, Yoko
Flynn, Patrick
Byrd, Kaelan H.
Coy, Jesse L.
Newman, Matthew T.
Scott, Jaime
Loo, Christopher
Lind, Evan F.
JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
[29] Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia
Wu, Xiaoyan
Wang, Lin
Qiu, Yining
Zhang, Bingyu
Hu, Zhenhua
Jin, Runming
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017, 12 : 8025 - 8034
[30] Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD+ Acute Myeloid Leukemia
Bregante, Javier
Schoenbichler, Anna
Poeloeske, Daniel
Degenfeld-Schonburg, Lina
Monzo Contreras, Garazi
Hadzijusufovic, Emir
de Araujo, Elvin D.
Valent, Peter
Moriggl, Richard
Orlova, Anna
CANCERS, 2021, 13 (24)

← 1 2 3 4 5 →